XML 55 R42.htm IDEA: XBRL DOCUMENT
v3.23.1

Equity Incentive and Employee Stock Purchase Plan (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract] |
Valuation Assumptions of Market-based Restricted Stock Awards Granted | The Monte Carlo valuation model used to estimate the fair value of the market-based awards granted utilized the following weighted-average assumptions:
| December 31, 2022 |  | December 31, 2021
Underlying stock price at valuation date | $ | 59.66 |  |  | $ | 57.06 |
Expected volatility | 43.8 | % |  | 35.1 | %
Risk-free interest rate | 3.6 | % |  | 1.3 | %
Contractual term | 8 years |  | 6.1 years
The Monte Carlo valuation model used by the Former Parent to estimate the fair value of market-based restricted stock awards granted utilized the following weighted-average assumptions:
| December 31, |  | December 31, |  |
2021 |  | 2020 |  |
Underlying stock price at valuation | $ | 113.27 |  |  | $ | 91.17 |  |  |
Expected volatility | 30.3 | % |  | 27.0 | % |  |
Risk-free interest rate | 1.3 | % |  | 0.7 | % |  |
Contractual term | 8 years |  | 8 years |  |
Restricted Stock Award Activity | Restricted stock activity for the years ended December 31, 2022 and 2021 is set forth below:
| Number of Shares |  | Weighted-Average Grant-Date Fair Value (1)
Nonvested at January 1, 2021 | — |  |  | $ | — |
Exchanged in Separation | 65,235 |  |  | 38.46 |
Granted | — |  |  | — |
Vested | — |  |  | — |
Canceled | — |  |  | — |
Nonvested at December 31, 2021 | 65,235 |  |  | $ | 38.46 |
Granted | 884 |  |  | 37.67 |
Vested | (30,703) |  |  | 38.50 |
Canceled | — |  |  | — |
Nonvested at December 31, 2022 | 35,416 |  |  | $ | 38.42 |
(1) The Company revised the grant date fair value of certain awards which were inaccurately disclosed related to the prior period. The Company determined that the update of this disclosure did not have a material impact to the current or prior period financial statements. The restricted stock award activity for the years ended December 31, 2021 and 2020 is set forth below:
| Shares |  | Weighted-Average Grant-Date Fair Value
Nonvested at January 1, 2020 | 37,674 |  |  | $ | 75.03 |
Granted | — |  |  | — |
Vested | (7,785) |  |  | 76.43
Canceled | (3,020) |  |  | 77.37
Nonvested at December 31, 2020 | 26,869 |  |  | $ | 57.21 |
Granted | — |  |  | — |
Vested | (6,189) |  |  | 74.52 |
Canceled | (6,850) |  |  | 83.14 |
Adjustment due to Separation | (13,830) |  |  | 53.72 |
Nonvested at December 31, 2021 | — |  |  | $ | — |
Restricted Stock Unit Activity | Restricted stock unit activity for the years ended December 31, 2022 and 2021 is set forth below:
| Number of Shares |  | Weighted-Average Grant-Date Fair Value (1) |  | Weighted-Average Remaining Contractual Life (in Years) |  | Aggregate Intrinsic Value
Outstanding at January 1, 2021 | — |  |  | $ | — |  |  |  |  |
Exchanged in Separation | 125,841 |  |  | 47.15 |  |  |  |  |
Granted | 887,431 |  |  | 51.22 |  |  |  |  |
Vested | — |  |  | — |  |  |  |  |
Canceled | (175) |  |  | 57.15 |  |  |  |  |
Outstanding at December 31, 2021 | 1,013,097 |  |  | $ | 50.71 |  |  |  |  |
Granted | 259,545 |  |  | 57.61 |  |  |  |  |
Vested | (165,494) |  |  | 54.72 |  |  |  |  |
Canceled | (24,697) |  |  | 56.20 |  |  |  |  |
Outstanding at December 31, 2022 | 1,082,451 |  |  | $ | 51.63 |  |  | 3.9 |  | $ | 58,192,566 |
Vested and expected to vest at December 31, 2022 | 710,764 |  |  | $ | 52.68 |  |  | 3.3 |  | $ | 38,210,673 |
(1) The Company revised the grant date fair value of certain awards which were inaccurately disclosed related to the prior period. The Company determined that the update of this disclosure did not have a material impact to the current or prior period financial statements. The restricted stock unit activity attributable to Consensus employees for the years ended December 31, 2021 and 2020 is set forth below:
| Number of Shares |  | Weighted-Average Remaining Contractual Life (in Years) |  | Aggregate Intrinsic Value
Outstanding at January 1, 2020 | 10,357 |  |  |  |  |
Granted | 5,431 |  |  |  |  |
Vested | (1,734) |  |  |  |  |
Canceled | (360) |  |  |  |  |
Outstanding at December 31, 2020 | 13,694 |  |  |  |  |
Granted | 4,416 |  |  |  |  |
Vested | (2,470) |  |  |  |  |
Canceled | (8,856) |  |  |  |  |
Adjustment due to Separation | (6,784) |  |  |  |  |
Outstanding at December 31, 2021 | — |  |  | 0.0 |  | $ | — |
Vested and expected to vest at December 31, 2021 | — |  |  | 0.0 |  | $ | — |
Valuation Assumptions of Purchase Plan | The compensation expense related to the Purchase Plan has been estimated utilizing the following assumptions:
| December 31, 2022 |  | December 31, 2021
Risk-free interest rate | 4.54% |  | 0.05%
Expected term (in years) | 0.5 |  | 0.5
Dividend yield | 0.00% |  | 0.00%
Expected volatility | 48.19% |  | 17.89%
Weighted average volatility | 48.19% |  | 17.89%
Stock Options Activity | The stock option activity attributable to Consensus employees for the years ended December, 2021 and 2020 is summarized as follows:
| Number of Shares |  | Weighted-Average Exercise Price |  | Weighted-Average Remaining Contractual Life (In Years) |  | Intrinsic Value
Options outstanding at January 1, 2020 | 8,710 |  |  | $ | 29.53 |  |  |  |  |
Granted | — |  |  | — |  |  |  |
Exercised | (250) |  |  | $ | 29.53 |  |  |  |  |
Canceled | — |  |  | — |  |  |  |
Options outstanding at December 31, 2020 | 8,460 |  |  | $ | 29.53 |  |  |  |  |
Granted | — |  |  |  |  |  |  |
Exercised | (250) |  |  | 29.53 |  |  |  |
Canceled | — |  |  |  |  |  |  |
Adjustment due to Separation | (8,210) |  |  |  |  |  |  |
Options outstanding at December 31, 2021 | — |  |  | $ | — |  |  | 0.0 |  | $ | — |
Exercisable at December 31, 2021 | — |  |  | $ | — |  |  | 0.0 |  | $ | — |
Vested and expected to vest at December 31, 2021 | — |  |  | $ | — |  |  | 0.0 |  | $ | — |

X
- Definition Schedule Of Share-Based Payment Award, Restricted Stock, Valuation Assumptions + References No definition available. + Details
Name: | ccs_ScheduleOfShareBasedPaymentAwardRestrictedStockValuationAssumptionsTableTextBlock
Namespace Prefix: | ccs_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration